Cardiovascular effects of hormone therapy for prostate cancer

about

Testosterone and dihydrotestosterone reduce platelet activation and reactivity in older men and women.

P2860

Q54962842-ADBF50F6-148E-4AFE-879C-DB2D2254A61C

P2860

Cardiovascular effects of hormone therapy for prostate cancer

Item

http://www.wikidata.org/entity/Q26801112

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Cardiovascular effects of hormone therapy for prostate cancer

@ast

Cardiovascular effects of hormone therapy for prostate cancer

@en

Cardiovascular effects of hormone therapy for prostate cancer

@nl

type

Item

label

Cardiovascular effects of hormone therapy for prostate cancer

@ast

Cardiovascular effects of hormone therapy for prostate cancer

@en

Cardiovascular effects of hormone therapy for prostate cancer

@nl

prefLabel

Cardiovascular effects of hormone therapy for prostate cancer

@ast

Cardiovascular effects of hormone therapy for prostate cancer

@en

Cardiovascular effects of hormone therapy for prostate cancer

@nl

P1476

Cardiovascular effects of hormone therapy for prostate cancer

@en

P2093

Jason F Lester

http://www.w3.org/2001/XMLSchema#string

Malcolm D Mason

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

Testosterone and the cardiovascular system: a comprehensive review of the basic science literature

Molecular cloning of human and rat complementary DNA encoding androgen receptors

Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized s

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.

The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial

Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies.

Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study.

Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.

P304

129-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DHPS.S50549

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281817914

http://www.w3.org/2001/XMLSchema#string

P698

26229507

http://www.w3.org/2001/XMLSchema#string

P932

4516188

http://www.w3.org/2001/XMLSchema#string

Cardiovascular effects of hormone therapy for prostate cancer

about

P2860

P2860

Cardiovascular effects of hormone therapy for prostate cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932